Angiotensin II in the evolution of experimental heart failure

Hypertension

Volumn 28, Issue 3, 1996, Pages 472-477

  Luchner, Andreas ^a   Stevens, Tracy L ^a   Borgeson, Daniel D ^a   Redfield, Margaret M ^a   Bailey, Jane E ^a   Sandberg, Sharon M ^a   Heublein, Denise M ^a   Burnett Jr , John C ^a  

^a MAYO CLINIC   (United States)

Author keywords

aorta; heart; heart failure; kidney; natriuretic peptide

Indexed keywords

ANGIOTENSIN; NATRIURETIC FACTOR;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOG; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE HYPERTROPHY; KIDNEY PERFUSION; NONHUMAN; PATHOPHYSIOLOGY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; SODIUM EXCRETION;

EID: 0029792316     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.3.472     Document Type: Article

References (32)

1. Hall JE. Control of sodium excretion by angiotensin II: intrarenal mechanisms and blood pressure regulation. Am J Physiol. 1986; 250:R960-R972.
2. Chan DP, Sandok EK, Aarhus LL, Heublein D, Burnett JC Jr. Renal-specific actions of angiotensin II receptor antagonism in the anesthetized dog. Am J Hypertens. 1992;5:354-360.
3. Kobayashi M, Furukawa Y, Chiba S. Positive chronotropic and inotropic effects of angiotensin II in the dog heart. Eur J Pharmacol. 1978;50:17-25.
4. Ichikawa I, Pfeffer JM, Pfeffer MA, Hostetter TH, Brenner BM. Role of angiotensin II in the altered renal function of congestive heart failure. Cire Res. 1984;55:669-675.
5. Dostal D, Baker B. Angiotensin II stimulation of left ventricular hypertrophy in adult rat heart. Am J Hypertens. 1992;5:276-280.
6. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation. 1991;83:1849-1865.
7. Pfeffer MA, Pfeffer JM, Steinberg C, Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation. 1985;72:406-412.
8. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987;316:1429-1435.
9. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
10. Redfield MM, Aarhus LL, Wright SR, Burnett JC Jr. Cardiorenal and neurohumoral function in a canine model of early left ventricular dysfunction. Circulation. 1993;87:2016-2022.
11. Stevens TL, Burnett JC Jr, Kinoshita M, Matsuda Y, Redfield MM. A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction. J Clin Invest. 1995;95:1101-1108.
12. Stevens TL, Borgeson DD, Luchner A, Wennberg P, Redfield MM, Burnett JC Jr. A modified model of tachycardia-induced cardiomyopathy: insights into humoral and renal adaptations. In: Spinale F, ed. Pathophysiology of Tachycardia-Induced Heart Failure. American Heart Association Monograph Series. Armonk, NY: Futura Publishing Co; 1996.
13. Schunkert H, Tang SS, Litwin SE, Diamant D, Riegger GAJ, Dzau VJ, Ingelfinger JR. Regulation of intrarenal and circulating renin-angiotensin systems in severe heart failure in the rat. Cardiovasc Res. 1993;23:731-735.
14. Burnett JC Jr, Kao PC, Hu DC, Heser D, Heublein DM, Granger J, Opgenorth T, Reeder G. Atrial natriuretic peptide elevation in congestive heart failure in the human. Science. 1986;231:1145-1147.
15. Haber J, Koerner T, Page LB, Klimann B, Purnode A. Application of a radioimmunoassay for angiotensin I to the physiologic measurement of plasma renin activity in normal human subjects. J Clin Endocrinol Merab. 1969;29:1349-1355.
16. Sando J, Haber E. A direct microassay for aldosterone in plasma extracts. J Clin Endocrinol Metab. 1978;47:391-396.
17. Clavell AL, Stingo AJ, Aarhus LL, Burnett JC Jr. Biological actions of brain natriuretic peptide in thoracic inferior vena cavai constriction. Am J Physiol. 1993;265:R1416-R1422.
18. Meng QC, Durand J, Chen YF, Oparil S. Simplified method for quantitation of angiotensin peptides in tissue. J Chromatogr. 1993; 614:19-22.
19. Lowry OH, Rosebrough NJ, Farr L, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;192:265-275.
20. Francis GS, Benedict C, Johnstone DE, Kirlin PC, Nicklas J, Liang CS, Kubo SH. Rudin-Toretsky E, Yusuf S. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation. 1990;82:1724-1729.
21. Pieruzzi F, Abassi ZA, Keiser HR. Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure. Circulation. 1995;92:3105-3112.
22. Hirsch AT, Talsness CE, Schunkert H, Paul M, Dzau VJ. Tissue specific activation of cardiac angiotensin convening enzyme in experimental heart failure. Circ Res. 1991;69:475-482.
23. Pinto YM, de Smet BG, van Gilst WH, Scholtens E, Monnink S, de Graeff PA, Wesseling H. Selective and time related activation of the cardiac renin-angiotensin system after experimental heart failure: relation to ventricular function and morphology. Cardiovasc Res. 1993;27:1933-1938.
24. Boer PH, Ruzicka M, Lear W, Harmsen E, Rosenthal J, Leenen FH. Stretch-mediated activation of cardiac renin gene. Am J Physiol. 1994;267(part 2):H1630-H1636.
25. Iwai N, Shimoike H, Kinoshita M. Cardiac renin-angiotensin system in the hypertrophied heart. Circulation. 1995;92:2690-2696.
26. Studer R, Reinecke H, Mueller B, Holtz J, Just H, Drexler H. Increased angiotensin-I converting enzyme gene expression in the failing human heart. J Clin Invest. 1994;94:301-310.
27. Urata H, Kinoshita A, Misono KS, Bumpus FM, Husain A. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem. 1990;25:22348-22357.
28. Huang H, Arnal JF, Llorens-Cortes C, Challah M, Alhenc-Gelas F, Corvol P, Michel JB. Discrepancy between plasma and lung angiotensin-converting enzyme activity in experimental congestive heart failure. Circ Res. 1994;75:454-461.
29. Kawaguchi H, Sawa H, Yasuda H. Rapid communication: effect of atrial natriuretic factor on angiotensin converting enzyme. J Mol Cell Cordiol. 1989;21:959-961.
30. Moe G, Naki G, Howard R, Armstrong PW. Dissociated angiotensin II activation and hypertrophy development in the atrium and ventricle in heart failure. Circulation. 1995;92(suppl I):I-62. Abstract.
31. Allan DK, McKnight JA, Kifor I, Coletti C, Hollenberg NK. Converting enzyme inhibition and renal tissue angiotensin II in the rat. Hypertension. 1994;24:516-522.
32. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 1992;327:685-691.